T. Rowe Price Associates’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6M Sell
1,046,215
-236,851
-18% -$1.36M ﹤0.01% 1227
2025
Q1
$10.5M Sell
1,283,066
-85,575
-6% -$698K ﹤0.01% 1110
2024
Q4
$12.9M Buy
1,368,641
+26,720
+2% +$252K ﹤0.01% 1092
2024
Q3
$14.3M Sell
1,341,921
-48,126
-3% -$514K ﹤0.01% 1064
2024
Q2
$13.8M Buy
1,390,047
+686
+0% +$6.81K ﹤0.01% 1046
2024
Q1
$16.4M Buy
1,389,361
+12,003
+0.9% +$141K ﹤0.01% 1023
2023
Q4
$19.5M Sell
1,377,358
-19,737
-1% -$280K ﹤0.01% 960
2023
Q3
$17M Buy
1,397,095
+4,481
+0.3% +$54.5K ﹤0.01% 952
2023
Q2
$17.5M Sell
1,392,614
-76,388
-5% -$959K ﹤0.01% 967
2023
Q1
$16.3M Sell
1,469,002
-21,193
-1% -$235K ﹤0.01% 971
2022
Q4
$18.2M Buy
1,490,195
+31,475
+2% +$384K ﹤0.01% 935
2022
Q3
$15.2M Sell
1,458,720
-7,275
-0.5% -$76K ﹤0.01% 984
2022
Q2
$15.7M Buy
1,465,995
+4,864
+0.3% +$52.2K ﹤0.01% 1228
2022
Q1
$13.8M Sell
1,461,131
-604,011
-29% -$5.72M ﹤0.01% 1316
2021
Q4
$23.9M Sell
2,065,142
-712,106
-26% -$8.22M ﹤0.01% 1244
2021
Q3
$26.5M Buy
2,777,248
+209,572
+8% +$2M ﹤0.01% 1224
2021
Q2
$24.8M Buy
2,567,676
+482,004
+23% +$4.65M ﹤0.01% 1250
2021
Q1
$20.6M Buy
2,085,672
+36,310
+2% +$359K ﹤0.01% 1269
2020
Q4
$47.3M Buy
2,049,362
+858,025
+72% +$19.8M ﹤0.01% 978
2020
Q3
$16.8M Buy
1,191,337
+70,084
+6% +$990K ﹤0.01% 1194
2020
Q2
$16.9M Buy
1,121,253
+171,408
+18% +$2.58M ﹤0.01% 1185
2020
Q1
$8.78M Buy
949,845
+6,198
+0.7% +$57.3K ﹤0.01% 1250
2019
Q4
$9.19M Buy
943,647
+83,870
+10% +$817K ﹤0.01% 1321
2019
Q3
$6.9M Sell
859,777
-4,804
-0.6% -$38.5K ﹤0.01% 1340
2019
Q2
$10.8M Buy
864,581
+1,236
+0.1% +$15.4K ﹤0.01% 1299
2019
Q1
$11.7M Sell
863,345
-1,932
-0.2% -$26.3K ﹤0.01% 1293
2018
Q4
$8.29M Sell
865,277
-1,623,357
-65% -$15.6M ﹤0.01% 1334
2018
Q3
$30.1M Sell
2,488,634
-3,427,311
-58% -$41.4M ﹤0.01% 1089
2018
Q2
$92.4M Buy
5,915,945
+966,312
+20% +$15.1M 0.01% 685
2018
Q1
$74.4M Sell
4,949,633
-4,113,678
-45% -$61.9M 0.01% 728
2017
Q4
$130M Buy
9,063,311
+971,280
+12% +$14M 0.02% 565
2017
Q3
$122M Buy
8,092,031
+5,277,190
+187% +$79.6M 0.02% 571
2017
Q2
$28.3M Sell
2,814,841
-26,989
-0.9% -$272K 0.01% 1043
2017
Q1
$20.3M Sell
2,841,830
-200,100
-7% -$1.43M ﹤0.01% 1156
2016
Q4
$15.1M Sell
3,041,930
-1,297,405
-30% -$6.45M ﹤0.01% 1221
2016
Q3
$32.1M Sell
4,339,335
-1,544,613
-26% -$11.4M 0.01% 959
2016
Q2
$32.1M Sell
5,883,948
-17,100
-0.3% -$93.4K 0.01% 933
2016
Q1
$49.9M Sell
5,901,048
-28,020
-0.5% -$237K 0.01% 770
2015
Q4
$57.5M Buy
5,929,068
+41,103
+0.7% +$399K 0.01% 714
2015
Q3
$82.4M Buy
5,887,965
+63,665
+1% +$891K 0.02% 621
2015
Q2
$82.4M Buy
5,824,300
+5,203,051
+838% +$73.6M 0.02% 663
2015
Q1
$6.76M Buy
+621,249
New +$6.76M ﹤0.01% 1422